Compare American Well Corp (AMWL) vs Atomera Incorporated (ATOM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Well Corp vs Atomera Incorporated — how do they compare? American Well Corp trades at $9.9 (market cap $165.58M), while Atomera Incorporated trades at $6.55 (market cap $256.50M). The key difference: Atomera Incorporated is the larger of the two by market cap, and American Well Corp is trading nearer its 52-week high, Atomera Incorporated nearer its low. Which is the better fit depends on your goals.
| AMWL | ATOM | |
|---|---|---|
Market Cap | $165.58M | $256.50M |
Sector | Health | Technology |
52-Week High | $9.91 | $12.11 |
52-Week Low | $3.78 | $1.99 |
Enterprise Value | -$9.66M | $216.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
ATOM trades at $6.63, down 2.93% with bearish technical signals. The company shows severe financial strain with negative gross profit margin of -520.83% and net income margin of -29,219.44% for 2025. Recent earnings misses and negative cash flow highlight operational challenges, though analyst consensus remains 100% buy rating based on technology licensing potential in semiconductor materials.
Outlook remains speculative with significant execution risk. The company's GaN-on-Silicon technology partnerships with Synopsys offer potential upside, but current financial metrics and consistent losses warrant caution. Investment opportunity exists only for risk-tolerant investors betting on technology adoption breakthroughs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Atomera Incorporated
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →
